• 2,300 women
    women were determined to be at high risk for breast cancer by the High Risk Screening Program in Ontario in 2015
  • 86%
    of cancer patients saw a registered dietitian at a regional cancer centre within 14 days of referral in 2016
  • 71%
    of stage III colon cancer patients received chemotherapy within 60 days of after surgery in 2014
  • 86%
    of all cancer surgery patients received their consult within the recommended wait time in 2016, and 87% received their surgery within the recommend wait time
  • Over 43,000
    patients were discussed at comprehensive multidisciplinary cancer conferences (MCCs) in fiscal year 2016/2017
  • About 13%
    of patients who undergo lung, prostate and colorectal surgery have an unplanned hospital visit following surgery
  • 79%
    of breast cancer patients had a guideline-recommended mammogram in the first follow-up year
  • 74%
    of colorectal cancer patients diagnosed in 2013 had a surveillance colonoscopy within 18 months of surgery
  • Over 100
    patient and family advisors, who vary by their type of cancer and experiences, represent diverse regions and work with Cancer Care Ontario to ensure a person-centred cancer system
  • 383,023
    unique patients were screened for symptom severity using Your Symptoms Matter – General Symptoms (YSM-General) in 2016
Click here to emailClick here to printClick here to share

Thyroid Cancer - Special Focus

 

Special Feature: A first look at the status of thyroid Cancer in Ontario

What is thyroid cancer?
  • Thyroid cancer is a cancerous tumour that starts in the cells of the thyroid.
  • The thyroid is a gland that is located at the base of the neck.
  • The thyroid helps control heart rate, blood pressure and body temperature.
thyroid cancer in Ontario
  • Thyroid cancer is the 8th most common cancer in Ontario.
  • Incidence rates are rising faster than any solid cancer, especially in women and in younger people.
  • In 2013, the number of women diagnosed in Ontario was almost 3.5 times the number of men diagnosed.
  • About 94% of thyroid cancers in Ontario are papillary thyroid cancer, which has a very good prognosis.
  • Thyroid cancer is caught early (stage I) in most people. When cancer is caught early it is easier to treat.
Treatment
  • Thyroid cancer is mainly treated with surgery, radioactive iodine-131 and thyroid hormone replacement.
  • In 2015, 89% of thyroid cancer patients in Ontario received thyroid surgery within the recommended wait time.
  • About 13% of patients have an unplanned hospital visit 30 days after thyroid surgery, which is lower than rates for other cancers.
  • There is currently a move towards more conservative treatment, such as less-than-total thyroidectomy and people receiving less intense radioactive iodine treatment or even none at all. This will result in a better quality of life for patients.
  • Most patients receive treatment locally, but many still travel to other regions to receive treatment. People should be getting both their surgery and radioactive iodine treatment as close to home as possible.
Recovery
  • The mortality rate has mostly stayed the same over time, about 0.5 deaths for 100,000 people.
  • The 5-year relative survival ratio for thyroid cancer is 95% for males and 99% for females.
  • Thyroid cancer has the highest survival rate of any cancer in Ontario.
  • High survival rates and increasing incidence means that the number of thyroid cancer survivors is increasing.
  • People who have been treated for thyroid cancer will need to take hormone replacement therapy and monitor their hormone levels for the rest of their lives to stay healthy and safe.